Dermal fibroblasts represent a potent major source of human eotaxin: In vitro production and cytokine-mediated regulation

Cytokine

Volumn 11, Issue 10, 1999, Pages 751-758

  Miyamasu, Misato ^a   Nakajima, Toshiharu ^a   Misaki, Yoshikata ^b   Izumi, Shinyu ^a   Tsuno, Nelson ^a   Kasahara, Tadashi ^c   Yamamoto, Kazuhiko ^a   Morita, Yutaka ^a   Hirai, Koichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

ELISA; Eotaxin; Fibroblast; IL 4; TNF

Indexed keywords

CYTOKINE; EOTAXIN; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC REACTION; ARTICLE; BRONCHUS MUCOSA; CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INTERSTITIUM; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SKIN FIBROBLAST; VASCULAR ENDOTHELIUM; VEIN;

ANIMALIA; BRONCHUS;

EID: 0032870119     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0487     Document Type: Article

References (36)

1. Gleich GJ, Adolphson CR, Leiferman KM. The biology of the eosinophilic leukocyte. Annu Rev Med. 44:1993;85-101.
2. Jose PJ, Griffiths Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med. 179:1994;881-887.
3. Baggiolini M. Eotaxin: a VIC (very important chemokine) of allergic inflammation? [editorial]. J Clin Invest. 97:1996;587.
4. Combadiere C, Ahuja SK, Murphy PM. Cloning and functional expression of a human eosinophil CC chemokine receptor. J Biol Chem. 270:1995;16491-16494.
5. Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, Ponath PD, Mackay CR. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest. 99:1997;178-184.
6. Yamada H, Hirai K, Miyamasu M, Iikura M, Misaki Y, Shoji S, Takaishi T, Kasahara T, Morita Y, Ito K. Eotaxin is a potent chemotaxin for human basophils. Biochem Biophys Res Commun. 231:1997;365-368.
7. Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, LaRosa GJ, Rao P, Ponath PD, Baggiolini M, Dahinden CA. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest. 100:1997;1137-1143.
8. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 277:1997;2005-2007.
9. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F. Differential expression of chemokine receptors and responsiveness of type 1 helpercells (Th1s) and Th2s. J Exp Med. 187:1998;129-134.
10. Kitaura M, Nakajima T, Imai T, Harada S, Combadiere C, Tiffany HL, Murphy PM, Yoshie O. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem. 271:1996;7725-7730.
11. Garcia Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med. 2:1996;449-456.
12. Lilly CM, Nakamura H, Kesselman H, Nagler Anderson C, Asano K, Garcia Zepeda EA, Rothenberg ME, Drazen JM, Luster AD. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest. 99:1997;1767-1773.
13. Bartels J, Schluter C, Richter E, Noso N, Kulke R, Christophers E, Schröder JM. Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants. Biochem Biophys Res Commun. 225:1996;1045-1051.
14. Lamkhioued B, Renzi PM, Abi-Younes S, Garcia-Zepta EA, Allakhverdi Z, Ghaffar O, Rothenberg MD, Luster AD, Hamid Q. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatic contributes to the chemotaxis of eosinophils to the sites of inflammation. J Immunol. 159:1997;4593-4601.
15. Mattoli S, Stacey MA, Sun G, Bellini A, Marini M. Eotaxin expression and eosinophilic inflammation in asthma. Biochem Biophys Res Commun. 236:1997;299-301.
16. Ying S, Robinson DS, Meng Q, Rottman J, Kennedy R, Ringler RD, Mackay CR, Daugherty BL, Springer MS, Durham SR, Williams TJ, Kay AB. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol. 27:1997;3507-3516.
17. Ponath PD, Qin S, Ringler DJ, Clark Lewis I, Wang J, Kassam N, Smith H, Shi X, Gonzalo JA, Newman W, Gutierrez Ramos JC, Mackay CR. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest. 97:1996;604-612.
18. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schröder J-M. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol. 160:1998;60-68.
19. Miyamasu M, Hirai K, Takahashi Y, Iida M, Yamaguchi M, Koshino T, Takaishi T, Morita Y, Ohta K, Kasahara T, Ito K. Chemotactic agonists induce cytokine generation in eosinophils. J Immunol. 154:1995;1339-1349.
20. Izumi S, Hirai K, Miyamasu M, Takahashi Y, Misaki Y, Takaishi T, Morita Y, Matsushima K, Ida N, Nakamura H, Kasahara T, Ito K. Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils. Eur J Immunol. 27:1997;816-824.
21. Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, Newman W, Gerard C, Mackay CR. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med. 183:1996;2437-2448.
22. Smith RS, Smith TJ, Blieden TM, Phipps RP. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol. 151:1997;317-322.
23. Kitamura Y, Kasugai T, Arizono N, Matsuda H. Development of mast cells and basophils: processes and regulation mechanisms. Am J Med Sci. 306:1993;185-191.
24. Tepper RI, Coffman RL, Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science. 257:1992;548-551.
25. Moser R, Groscurth P, Carballido JM, Bruijnzeel PL, Blaser K, Heusser CH, Fehr J. Interleukin-4 induces tissue eosinophilia in mice: correlation with its in vitro capacity to stimulate the endothelial cell-dependent selective transmigration of human eosinophils. J Lab Clin Med. 122:1993;567-575.
26. Rothenberg ME, Luster AD, Leder P. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci U S A. 92:1995;8960-8964.
27. Coffman RL, Lebman DA, Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol. 54:1993;229-270.
28. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, Newman W, Luscinskas FW, Gimbrone MA Jr, McIntyre BW, Bochner BS. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol. 148:1992;1086-1092.
29. Standiford TJ, Strieter RM, Chensue SW, Westwick J, Kasahara K, Kunkel SL. IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J Immunol. 145:1990;1435-1439.
30. Standiford TJ, Strieter RM, Kasahara K, Kunkel SL. Disparate regulation of interleukin 8 gene expression from blood monocytes, endothelial cells, and fibroblasts by interleukin 4. Biochem Biophys Res Commun. 171:1990;531-536.
31. Rathanaswami P, Hachicha M, Schall TJ, McColl SR. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem. 268:1993;5834-5839.
32. Donnelly RP, Crofford LJ, Freeman SL, Buras J, Remmers E, Wilder RL, Fenton MJ. Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-κB activity in monocytes and fibroblasts. J Immunol. 151:1993;5603-5612.
33. Xia Y, Pauza ME, Feng L, Lo D. RelB regulation of chemokine expression modulates local inflammation. Am J Pathol. 151:1997;375-387.
34. Kitayama J, Nagawa H, Yasuhara H, Tsuno N, Kimura W, Shibata Y, Muto T. Suppressive effect of basic fibroblast growth factor on transendothelial emigration of CD4(+) T-lymphocyte. Cancer Res. 54:1994;4729-4733.
35. Nakajima T, Yamada H, Iikura M, Miyamasu M, Izumi S, Shida H, Ohta K, Imai T, Yoshie O, Motizuki M, Schröder Jens-M, Morita Y, Yamamoto K, Hirai K. Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett. 434:1998;226-230.
36. Miyamasu M, Misaki Y, Izumi S, Takaishi T, Motita Y, Nakamura H, Matsushima K, Kasahara T, Hirai K. Glucocorticoids inhibit chemokine generation by human eosinophils. J Allergy Clin Immunol. 101:1998;75-83.